Carlos Stecca

8PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 04, 2026
Olaparib maintenance versus placebo or standard of care in ovarian cancer: a biomarker-driven systematic review and meta-analysis of randomized trials.

|Nov 06, 2025
When Cancer Becomes a Headline: Reflections From the Clinic.

Carlos Eduardo Stecca

|Jul 27, 2024
EGFR-Tyrosine Kinase Inhibitor Retreatment in Non-Small-Cell Lung Cancer Patients Previously Exposed to EGFR-TKI: A Systematic Review and Meta-Analysis.

Isabella Michelon, Maysa Vilbert, Caio Ernesto do Rego Castro

|Jun 18, 2024
Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials.

Francisco Cezar Aquino de Moraes, Vitor Kendi Tsuchiya Sano, Caroline R M Pereira

|May 25, 2024
Cyclin-Dependent Kinase 4/6 Inhibitors Plus Endocrine Therapy versus Endocrine Therapy Alone for HR-Positive, HER-2-Negative Early Breast Cancer: Meta-Analysis of Phase III Randomized Clinical Trials.

Francisco Cezar Aquino de Moraes, Gustavo de Oliveira Almeida, Vinícius Freire Costa Alves

|Nov 29, 2023
PD-1/PD-L1 inhibitors plus carboplatin and paclitaxel compared with carboplatin and paclitaxel in primary advanced or recurrent endometrial cancer: a systematic review and meta-analysis of randomized clinical trials.

Francisco Cezar Aquino de Moraes, Eric Pasqualotto, Lucca Moreira Lopes

Pageof 2

Frequent Collaborators

3 joint publications

Francisco Cezar Aquino de Moraes

2 joint publications

Marianne Rodrigues Fernandes

2 joint publications

Maria Cristina Figueroa Magalhães

2 joint publications

Maysa Vilbert